218 related articles for article (PubMed ID: 2439402)
1. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
Willars GB; Calcutt NA; Tomlinson DR
Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
[TBL] [Abstract][Full Text] [Related]
2. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Robinson JP; Willars GB; Tomlinson DR; Keen P
Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
[TBL] [Abstract][Full Text] [Related]
3. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
[TBL] [Abstract][Full Text] [Related]
4. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
Dahlin LB; Archer DR; McLean WG
Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
[TBL] [Abstract][Full Text] [Related]
5. Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.
Tomlinson DR; Willars GB; Calthrop-Owen EF
Exp Neurol; 1987 Apr; 96(1):194-202. PubMed ID: 2435570
[TBL] [Abstract][Full Text] [Related]
6. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
[TBL] [Abstract][Full Text] [Related]
7. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
Tomlinson DR; Sidenius P; Larsen JR
Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
[TBL] [Abstract][Full Text] [Related]
8. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
9. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
Tomlinson DR; Townsend J; Fretten P
Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918
[TBL] [Abstract][Full Text] [Related]
10. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
Mayer JH; Tomlinson DR; McLean WG
J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity.
Calcutt NA; Tomlinson DR; Willars GB
J Neurochem; 1988 May; 50(5):1478-83. PubMed ID: 2452237
[TBL] [Abstract][Full Text] [Related]
12. Statil-sensitive polyol formation in nerve of galactose-fed mice.
Calcutt NA; Willars GB; Tomlinson DR
Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544
[TBL] [Abstract][Full Text] [Related]
13. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats.
Willars GB; Calcutt NA; Tomlinson DR
J Neurol Sci; 1991 Jul; 104(1):46-51. PubMed ID: 1717661
[TBL] [Abstract][Full Text] [Related]
14. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
16. Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.
McLean WG
Diabetologia; 1988 Jul; 31(7):443-8. PubMed ID: 2464514
[TBL] [Abstract][Full Text] [Related]
17. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
[TBL] [Abstract][Full Text] [Related]
18. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.
Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB
Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
Kofo-Abayomi A; Lucas PD
J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
[TBL] [Abstract][Full Text] [Related]
20. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
Naeser P; Brolin SE; Eriksson UJ
Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
